Literature DB >> 10457538

Melatonin sensitivity to dim white light in affective disorders.

P J Nathan1, G D Burrows, T R Norman.   

Abstract

Both dim and bright light has been shown to suppress the nocturnal secretion of the pineal hormone melatonin. Early reports suggests that an abnormal response to light occurs in patients with bipolar affective disorder, where as patients with major depressive disorder respond similarly to controls. It has been suggested that this abnormal sensitivity of the melatonin response to light could be a trait marker of bipolar affective disorder. However reports lack consistency. Hence, we investigated the melatonin suppression by dim light (200 lux) in patients with bipolar affective disorder, seasonal affective disorder and major depressive disorder. Results suggest that a supersensitive melatonin suppression to light in bipolar affective disorder (p < .005), and seasonal affective disorder (p < .05), whereas patients with major depressive disorder display similar suppression to controls. The supersensitivity may be a mechanism where by phase-delayed rhythms, are resynchronised to a new circadian position. Conversely, an abnormality may exist in the pathway from the retina to the suprachiamatic nucleus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457538     DOI: 10.1016/S0893-133X(99)00018-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  29 in total

1.  The effects of prior light history on the suppression of melatonin by light in humans.

Authors:  Marc Hébert; Stacia K Martin; Clara Lee; Charmane I Eastman
Journal:  J Pineal Res       Date:  2002-11       Impact factor: 13.007

Review 2.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

3.  The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose.

Authors:  E M McGlashan; L S Nandam; P Vidafar; D R Mansfield; S M W Rajaratnam; S W Cain
Journal:  Psychopharmacology (Berl)       Date:  2018-09-15       Impact factor: 4.530

Review 4.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

5.  Serum lipid levels in seasonal affective disorder.

Authors:  Edda Pjrek; Dietmar Winkler; David W Abramson; Anastasios Konstantinidis; Jürgen Stastny; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-05       Impact factor: 5.270

6.  Relationships between circadian measures, depression, and response to antidepressant treatment: A preliminary investigation.

Authors:  Leslie M Swanson; Helen J Burgess; Edward D Huntley; Holli Bertram; Ann Mooney; Jennifer Zollars; Richard Dopp; Robert Hoffmann; Roseanne Armitage; J Todd Arnedt
Journal:  Psychiatry Res       Date:  2017-03-08       Impact factor: 3.222

Review 7.  The relationship between bipolar disorder, seasonality, and premenstrual symptoms.

Authors:  Deborah R Kim; Kathryn A Czarkowski; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

Review 8.  Chronobiology of bipolar disorder: therapeutic implication.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

9.  Increased sensitivity to light-induced melatonin suppression in premenstrual dysphoric disorder.

Authors:  Barbara L Parry; Charles J Meliska; Diane L Sorenson; Ana Lopez; Luis Fernando Martínez; Richard L Hauger; Jeffrey A Elliott
Journal:  Chronobiol Int       Date:  2010-08       Impact factor: 2.877

10.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.